Navigation Links
Clinton Foundation Eases Over-Pricing Of AIDS Drugs Once More

Former US president Bill Clinton has once again lent a helping hand to HIV/ AIDS victims. After a fallout between the Brazil government and drug giant Merck over pricey anti-retroviral drugs, the Clinton foundation has helped diffuse the situation. Clinching a deal with two Indian pharmaceutical companies Cipla and Matrix, Bill Clinton announced the tie-up with the companies to provide second-line AVR drugs and a next generation one-pill-a-day drug.

Cipla and Matrix agreed to price their drugs on a cost-plus basis and collaborate with Clinton Foundation HIV and AIDS Initiative (CHAI) to lower production costs, in part, by securing lower prices for key raw materials and by addressing major chemistry challenges.

These agreements lower prices for 16 formulations of ARVs, which will be available to 66 developing countries in Africa, Asia, Latin America and the Caribbean through the Clinton Foundations Procurement Consortium, a release from CHAI added.

Bill Clinton was quoted: Seven million people in the developing world are in need of treatment for HIV/AIDS. We are trying to meet that need with the best medicine available today, and at prices that low-and middle-income countries can afford. I applaud Cipla and Matrix for their commitment to lower the cost of new drugs at the forefront of the fight against AIDS, and I thank UNITAID for the funds.

The AIDS virus infects nearly 39 million people globally, and has killed 25 million people since it was identified 25 years ago. Virtually all (95 percent) of people infected with the virus live in the developing world.

Experts say that by the year 2010, nearly half a million people in developing countries will need the drugs which currently cost far more money than the majority of developing countries can afford.

As Clinton was reported saying- companies will not live or die because of high price premiums for AIDS drugs in middle-income countries, but pati ents may.

The former US president states that while he upholds the belief in intellectual property and understands that manufacturers need to earn profits to keep the discovery and supply of AIDS drugs sustainable, that creed should not prevent essential life-saving medicines reaching those who need them in low and middle-income countries.


'"/>




Related medicine news :

1. Clintons new problem - Is the outgoing American president suffering from skin cancer?
2. AIDS testing gets support from Bill Clinton
3. Bill Clinton On A Kill, To Bell The Bulge Out of Schools
4. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
5. Clinton, Gates Highlight Treatment, Discrimination of AIDS
6. Powerful Synergy: Botswana and Clinton foundation To Sign MOU
7. Clinton’s Nutrition Deal Cuts Junk Food on School Menu
8. Bill Clinton Says US Healthcare System Immoral
9. Hillary Clinton Speaks Up Strongly for Stem Cell Research
10. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
11. Kalam To Lay Foundation Of Vellore Research Center
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... ... 2017 , ... An August 3rd article on Reuters covers a new University of ... JAMA (the Journal of the American Medical Association). The study found that a lower percentage ... 30, when compared to patients with lower BMIs. At present, weight loss patients must have ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, the leading ... was acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the ... industry’s leading suppliers, brokers, distributors and retailers. The Data Council will become a ...
(Date:8/16/2017)... ... August 16, 2017 , ... In ... They celebrate 30 years in business this year, and they’re marking the milestone ... space to serve their patients. , It stands to reason that, given ...
(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance & ... program. Partnering once again with Boys & Girls Clubs of Greater Kansas City, ... area’s very own American Idol. With all proceeds benefitting local worthy causes, donations ...
(Date:8/16/2017)... ... ... Paul Vitenas, MD, FACS , is honored to announce that he ... the nation’s top physicians, in a variety of specialties. This marks the fourth year ... Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider of information on ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
Breaking Medicine Technology: